A team of scientists, led by the University of Liverpool, has developed a diagnostic test for esophageal cancer using an extremely intense source of infrared light to image tissue taken from patients with Barrett's Esophagus, according to a Science and Technology Facilities Council news release.
Esophageal cancer is often caught in later stages, but Barrett's Esophagus is a precursor to cancer. Treatment at this stage can often prevent or cure esophageal cancer. Using the InfraRed Free Electron Laser at the ALICE prototype accelerator at STFC's Daresbury Laboratory in the U.K., scientists carried out a blind study of historical endoscopic samples from patients with Barrett's Esophagus. By detecting changes in the samples, they developed a diagnostic test for the disease.
Related Articles on Gastroenterology:
Boston Scientific Launches Expect19 Flex Endoscopic Ultrasound Aspiration Needle
Report: Capsule Endoscopy Market Has Grown 12.9% Annually Since 2007
GE to Invest in Israeli Company That Developed Swallowable Endoscopic Capsules
Esophageal cancer is often caught in later stages, but Barrett's Esophagus is a precursor to cancer. Treatment at this stage can often prevent or cure esophageal cancer. Using the InfraRed Free Electron Laser at the ALICE prototype accelerator at STFC's Daresbury Laboratory in the U.K., scientists carried out a blind study of historical endoscopic samples from patients with Barrett's Esophagus. By detecting changes in the samples, they developed a diagnostic test for the disease.
Related Articles on Gastroenterology:
Boston Scientific Launches Expect19 Flex Endoscopic Ultrasound Aspiration Needle
Report: Capsule Endoscopy Market Has Grown 12.9% Annually Since 2007
GE to Invest in Israeli Company That Developed Swallowable Endoscopic Capsules